LENSAR (NASDAQ:LNSR) Releases Quarterly Earnings Results, Misses Estimates By $1.40 EPS

LENSAR (NASDAQ:LNSR) released its quarterly earnings data on Thursday. The company reported ($1.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($1.40), Zacks reports. LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%. The business had revenue of $16.73 million during the quarter, compared to the consensus estimate of $14.95 million. LENSAR updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

LENSAR Stock Up 12.1 %

LENSAR stock traded up $1.31 during trading hours on Friday, hitting $12.18. The stock had a trading volume of 139,808 shares, compared to its average volume of 92,765. LENSAR has a one year low of $2.67 and a one year high of $13.03. The business’s 50 day simple moving average is $9.47 and its 200-day simple moving average is $6.99. The stock has a market cap of $141.47 million, a price-to-earnings ratio of -8.34 and a beta of 0.66.

Analysts Set New Price Targets

Separately, Lake Street Capital increased their price target on LENSAR from $12.00 to $16.00 and gave the stock a “buy” rating in a research report on Friday.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.